These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12235705)

  • 21. Increasing benefit of magnetic resonance imaging in multiple sclerosis.
    Pyhtinen J; Karttunen A; Tikkakoski T
    Acta Radiol; 2006 Nov; 47(9):960-71. PubMed ID: 17077049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
    Barkhof F; Rocca M; Francis G; Van Waesberghe JH; Uitdehaag BM; Hommes OR; Hartung HP; Durelli L; Edan G; Fernández O; Seeldrayers P; Sørensen P; Margrie S; Rovaris M; Comi G; Filippi M;
    Ann Neurol; 2003 Jun; 53(6):718-24. PubMed ID: 12783417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and therapeutic dilemmas.
    Brinar VV
    Clin Neurol Neurosurg; 2004 Jun; 106(3):180-6. PubMed ID: 15177767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis.
    Blumenthal S
    Radiol Technol; 2006; 77(4):309-21, quiz 322-5. PubMed ID: 16543484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relapsing-remitting inflammatory disease of the central nervous system with normal MRI: multiple sclerosis or phenocopy in a series of 15 patients].
    Lebrun C; Bourg V; Chanalet S; Chatel M
    Rev Neurol (Paris); 2003 Apr; 159(4):397-404. PubMed ID: 12773868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance evidence of cortical onset of multiple sclerosis.
    Calabrese M; Gallo P
    Mult Scler; 2009 Aug; 15(8):933-41. PubMed ID: 19667021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI in the diagnosis of pediatric multiple sclerosis.
    Callen DJ; Shroff MM; Branson HM; Lotze T; Li DK; Stephens D; Banwell BL
    Neurology; 2009 Mar; 72(11):961-7. PubMed ID: 19038852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum uric acid and multiple sclerosis.
    Sotgiu S; Pugliatti M; Sanna A; Sotgiu A; Fois ML; Arru G; Rosati G
    Neurol Sci; 2002 Oct; 23(4):183-8. PubMed ID: 12536287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pediatric multiple sclerosis and variants.
    Pohl D; Waubant E; Banwell B; Chabas D; Chitnis T; Weinstock-Guttman B; Tenembaum S;
    Neurology; 2007 Apr; 68(16 Suppl 2):S54-65. PubMed ID: 17438239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and disease modifying treatments in multiple sclerosis.
    Zajicek J
    Postgrad Med J; 2005 Sep; 81(959):556-61. PubMed ID: 16143683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria.
    Nielsen JM; Korteweg T; Barkhof F; Uitdehaag BM; Polman CH
    Ann Neurol; 2005 Nov; 58(5):781-3. PubMed ID: 16240352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.
    van Winsen LM; Hooper-van Veen T; van Rossum EF; Koper JW; Barkhof F; Polman CH; Uitdehaag BM
    J Neuroimmunol; 2007 May; 186(1-2):150-5. PubMed ID: 17395275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial effects on the clinical course of multiple sclerosis.
    Hensiek AE; Seaman SR; Barcellos LF; Oturai A; Eraksoi M; Cocco E; Vecsei L; Stewart G; Dubois B; Bellman-Strobl J; Leone M; Andersen O; Bencsik K; Booth D; Celius EG; Harbo HF; Hauser SL; Heard R; Hillert J; Myhr KM; Marrosu MG; Oksenberg JR; Rajda C; Sawcer SJ; Sørensen PS; Zipp F; Compston DA
    Neurology; 2007 Jan; 68(5):376-83. PubMed ID: 17261686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis in children.
    Thomas T; Banwell B
    Semin Neurol; 2008 Feb; 28(1):69-83. PubMed ID: 18256988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A calculation method for semi automatic follow up of multiple sclerosis by magnetic resonance eco planar perfusion imaging.
    Placidi G; Sabatini M; Gallucci M; Sotgiu A
    Stud Health Technol Inform; 2003; 95():164-9. PubMed ID: 14663981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis.
    Bagheri MH; Meshksar A; Nabavizadeh SA; Borhani-Haghighi A; Ashjazadeh N; Nikseresht AR
    Acad Radiol; 2008 Jan; 15(1):15-23. PubMed ID: 18078903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
    Ranjeva JP; Audoin B; Pelletier J; Confavreux C
    Rev Prat; 2006 Jun; 56(12):1326-35. PubMed ID: 16948221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.